Downregulation of miR‑224‑5p in prostate cancer and its relevant molecular mechanism via TCGA, GEO database and in silico analyses.

作者: Bin‑Liang Gan , Li‑Jie Zhang , Li Gao , Fu‑Chao Ma , Rong‑Quan He

DOI: 10.3892/OR.2018.6766

关键词:

摘要: The function of the expression microRNA (miR)-224-5p in prostate adenocarcinoma (PCa) remains to be elucidated, therefore, present study aimed investigate clinical significance and potential molecular mechanism miR-224-5p PCa. Data on PCa were extracted from Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), ArrayExpress previous literature, meta-analyses with standardized mean difference (SMD) summary receiver operating characteristic (sROC) methods performed for statistical analyses. prospective target genes collected by overlapping differentially expressed mRNAs TCGA GEO, predicted miRWalk2.0. Subsequently, silico analysis was examine associated pathways markedly lower PCa; overall SMD −0.562, sROC area under curve 0.80. In addition, Kyoto Encyclopedia Genes Genomes revealed that largely enriched amino sugar nucleotide metabolism signaling pathway, three [UDP-N-acetylglucosamine pyrophosphorylase 1 (UAP1), hexokinase 2 (HK2) chitinase (CHIT1)] this pathway showed higher (P<0.05). key protein-protein interaction network [DNA topoisomerase 2-α (TOP2A), ATP citrate lyase (ACLY) ribonucleotide reductase regulatory subunit M2 (RRM2)] exhibited significantly increased results suggested downregulated may progression prognosis Furthermore, likely exerts its effects targeting genes, including UAP1, HK2, CHIT1, TOP2A, ACLY RRM2. However, vivo vitro experiments are required confirm these findings.

参考文章(47)
Shuai Li, Hui Min Meng, Li Qiang Qi, Lin Gu, Feng Zhou, MicroRNA and histopathological characterization of pure mucinous breast carcinoma. Cancer biology and medicine. ,vol. 10, pp. 22- 27 ,(2013) , 10.7497/J.ISSN.2095-3941.2013.01.004
Zhuo-Yuan Lin, Ya-Qiang Huang, Yan-Qiong Zhang, Zhao-Dong Han, Hui-Chan He, Xiao-Hui Ling, Xin Fu, Qi-Shan Dai, Chao Cai, Jia-Hong Chen, Yu-Xiang Liang, Fu-Neng Jiang, Wei-De Zhong, Fen Wang, Chin-Lee Wu, MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1 International Journal of Cancer. ,vol. 135, pp. 541- 550 ,(2014) , 10.1002/IJC.28707
Zhen Li, Bi-Qing Li, Min Jiang, Lei Chen, Jian Zhang, Lin Liu, Tao Huang, Prediction and analysis of retinoblastoma related genes through gene ontology and KEGG. BioMed Research International. ,vol. 2013, pp. 304029- 304029 ,(2013) , 10.1155/2013/304029
Wendy E. Barrington, Jeannette M. Schenk, Ruth Etzioni, Kathryn B. Arnold, Marian L. Neuhouser, Ian M. Thompson, M. Scott Lucia, Alan R. Kristal, Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT) JAMA Oncology. ,vol. 1, pp. 342- 349 ,(2015) , 10.1001/JAMAONCOL.2015.0513
Yasheng Huang, Xiyong Liu, Yuan-Hung Wang, Shauh-Der Yeh, Chi-Long Chen, Rebecca A. Nelson, Peiguo Chu, Timothy Wilson, Yun Yen, The prognostic value of ribonucleotide reductase small subunit M2 in predicting recurrence for prostate cancers Urologic Oncology: Seminars and Original Investigations. ,vol. 32, pp. 51.e9- 51.e19 ,(2014) , 10.1016/J.UROLONC.2013.08.002
H M Itkonen, N Engedal, E Babaie, M Luhr, I J Guldvik, S Minner, J Hohloch, M C Tsourlakis, T Schlomm, I G Mills, UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N -linked glycosylation Oncogene. ,vol. 34, pp. 3744- 3750 ,(2015) , 10.1038/ONC.2014.307
Hao FU, Hui-chan He, Zhao-dong Han, Yue-ping Wan, Hong-wei Luo, Ya-qiang Huang, Chao Cai, Yu-xiang Liang, Qi-shan Dai, Fu-neng Jiang, Wei-de Zhong, MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer Tumor Biology. ,vol. 36, pp. 1983- 1991 ,(2015) , 10.1007/S13277-014-2805-0
Yueping Wan, Zhao-chang Zeng, Ming Xi, Song Wan, Wei Hua, Yuan-ling Liu, Yu-lin Zhou, Hong-wei Luo, Fu-neng Jiang, Wei-de Zhong, Dysregulated microRNA-224/apelin axis associated with aggressive progression and poor prognosis in patients with prostate cancer Human Pathology. ,vol. 46, pp. 295- 303 ,(2015) , 10.1016/J.HUMPATH.2014.10.027
Piet Ost, Alberto Bossi, Karel Decaestecker, Gert De Meerleer, Gianluca Giannarini, R. Jeffrey Karnes, Mack Roach, Alberto Briganti, Metastasis-directed Therapy of Regional and Distant Recurrences After Curative Treatment of Prostate Cancer: A Systematic Review of the Literature European Urology. ,vol. 67, pp. 852- 863 ,(2015) , 10.1016/J.EURURO.2014.09.004
Helle Kristensen, Christa Haldrup, Siri Strand, Kamilla Mundbjerg, Martin M. Mortensen, Kasper Thorsen, Marie Stampe Ostenfeld, Peter J. Wild, Christian Arsov, Wolfgang Goering, Tapio Visakorpi, Lars Egevad, Johan Lindberg, Henrik Grönberg, Søren Høyer, Michael Borre, Torben F. Ørntoft, Karina D. Sørensen, Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy. Clinical Cancer Research. ,vol. 20, pp. 2169- 2181 ,(2014) , 10.1158/1078-0432.CCR-13-2642